Future-Ready Solutions for Product Quality Challenges

This case study details ProPharma Group's strategic response to a significant increase in product quality complaints and safety issues faced by a major client in the JAPAC region from late 2022 to 2023. The document outlines a tri-fold strategy aimed at enhancing operational capacity, improving efficiency, and managing costs effectively. ProPharma implemented a tiered support system that integrated the expertise of offshore teams in India and the Philippines with the Australia-based team. The case study discusses the operational and financial challenges posed by the surge in case volumes, emphasizing the need for innovative solutions to maintain service quality while controlling costs. It also highlights the roles of the India and Philippines teams in managing written and verbal communications, respectively. The results of this initiative demonstrated improved operational metrics, zero critical findings in quality assurance assessments, and strengthened onshore capabilities, leading to the client's decision to expand their engagement with ProPharma.